 other drug among the 20,000 drugs the FDA regulates. And those data showed that serious complications are exceedingly rare, fewer than 1% of the time. So the FDA relied on its adverse event data, but it also concedes that that data cannot be used to estimate the incidence of adverse events or indicate the safety profile of